The Ventricular Catheter Placement Study: Assessment of Efficacy and Safety of an Ultrasound Guided Shunt Insertion Technique

June 12, 2012 updated by: University of Utah
Shunt failure remains a significant problem in pediatric patients with hydrocephalus. If reliable techniques for the accurate placement of ventricular catheters can be developed, shunt survival may improve. The purpose of this study is to assess the efficacy and safety of the ultrasound guided shunt insertion technique in the hands of experienced surgeons. The primary outcome measure is ventricular catheter location determined from post-operative brain images. The study is being conducted by the Hydrocephalus Clinical Research Network (HCRN), a network established to conduct multi-institutional clinical trials on pediatric hydrocephalus. Pediatric neurosurgeons at HCRN centers enrolled in this study will perform either ultrasound guided shunt surgery or a conventional shunt surgery. Patients who undergo conventional shunt surgery will serve as a contemporary control group.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

67

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5G 1X8
        • Sick Children's Hospital
    • Alabama
      • Birmingham, Alabama, United States, 35233
        • Children's Hospital of Alabama
    • Texas
      • Houston, Texas, United States, 77030
        • Texas Children's Hospital
    • Utah
      • Salt Lake City, Utah, United States, 84113
        • Primary Children's Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Pediatric hydrocephalus patients undergoing first time shunt placement for hydrocephalus.

Description

Inclusion Criteria:

  • Patients must have clinical and radiographic evidence of hydrocephalus as determined by a pediatric neurosurgeon and require a ventriculoperitoneal shunt (atrial, pleural, gallbladder and other shunt systems are excluded)
  • Patients can have no prior history of shunt insertion for hydrocephalus. A history of an external ventricular drain, subgaleal reservoir-catheter, or subgaleal shunt is permissible
  • Patients must be less than 18 years of age at the time of shunt insertion

Exclusion Criteria:

  • Active CSF or abdominal infection
  • Spread of tumor in the subarachnoid space documented on enhanced imaging (CT or MRI) of the head or spine
  • CSF leak without hydrocephalus
  • Pseudotumor cerebri
  • Dandy-Walker malformation or arachnoid cyst as a cause of hydrocephalus
  • Loculations within the ventricular system
  • Hydranencephaly, alobar holoprosencephaly or any other congenital anomaly of the brain that severely distorts the ventricular anatomy such that ventricular catheter location cannot be determined
  • Other systemic disorders that would preclude the insertion/revision of a ventricular shunt
  • Other difficulties that would preclude follow-up at one year (e.g. terminal illness with life expectancy less than 1 year)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The primary endpoint for the study is ventricular catheter location (VCL) as assessed on the first post-operative scan (US, CT, or MRI brain).
Time Frame: The first post-operative scan will only be used in the study if it occurs within 105 days of shunt insertion.
The first post-operative scan will only be used in the study if it occurs within 105 days of shunt insertion.

Secondary Outcome Measures

Outcome Measure
Time Frame
Shunt survival will be reported.
Time Frame: Up to one year after the date of shunt placement.
Up to one year after the date of shunt placement.
Any complications, intraoperative and postoperative, will be reported.
Time Frame: From the time of surgery until the time the subject is discharged from the hospital.
From the time of surgery until the time the subject is discharged from the hospital.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: William Whitehead, MD, MPH, HCRN, Texas Children's Hospital
  • Principal Investigator: Jay Riva-Cambrin, MD, HCRN, Primary Children's Medical Center
  • Principal Investigator: Abhaya Kulkarni, MD, PhD, HCRN, Sick Children's Hospital, Toronto, Ontario
  • Principal Investigator: Jay Wellons, MD, HCRN, Children's Hosptial of Alabama
  • Principal Investigator: John Kestle, MD, Chair, Hydrocephalus Clinical Research Network

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2008

Primary Completion (Actual)

February 1, 2010

Study Completion (Actual)

March 1, 2011

Study Registration Dates

First Submitted

November 2, 2009

First Submitted That Met QC Criteria

November 2, 2009

First Posted (Estimate)

November 4, 2009

Study Record Updates

Last Update Posted (Estimate)

June 14, 2012

Last Update Submitted That Met QC Criteria

June 12, 2012

Last Verified

June 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • 32371
  • 1RC1NS068943-01 (U.S. NIH Grant/Contract)
  • HCRN 002 (Other Identifier: HCRN Protocol Number)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pediatric Hydrocephalus

Subscribe